Alpine Woods Capital Investors LLC boosted its stake in Medtronic PLC (NYSE:MDT) by 0.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 154,300 shares of the medical technology company’s stock after acquiring an additional 1,000 shares during the quarter. Alpine Woods Capital Investors LLC’s holdings in Medtronic PLC were worth $13,694,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Medtronic PLC by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 102,321,656 shares of the medical technology company’s stock valued at $8,243,034,000 after acquiring an additional 4,412,536 shares in the last quarter. BlackRock Inc. lifted its position in Medtronic PLC by 2,513.4% in the 1st quarter. BlackRock Inc. now owns 87,035,376 shares of the medical technology company’s stock valued at $7,011,571,000 after acquiring an additional 83,705,052 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Medtronic PLC by 3.0% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 58,646,070 shares of the medical technology company’s stock valued at $4,724,526,000 after acquiring an additional 1,729,715 shares in the last quarter. Lazard Asset Management LLC lifted its position in Medtronic PLC by 1,061.4% in the 1st quarter. Lazard Asset Management LLC now owns 13,678,772 shares of the medical technology company’s stock valued at $1,101,960,000 after acquiring an additional 12,500,992 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in Medtronic PLC by 7.3% in the 1st quarter. Geode Capital Management LLC now owns 13,308,812 shares of the medical technology company’s stock valued at $1,070,622,000 after acquiring an additional 906,581 shares in the last quarter. 80.63% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts recently commented on MDT shares. BidaskClub raised shares of Medtronic PLC from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 17th. Zacks Investment Research lowered shares of Medtronic PLC from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Jefferies Group LLC reiterated a “buy” rating and issued a $103.00 price target on shares of Medtronic PLC in a research note on Thursday, August 3rd. UBS AG reiterated an “overweight” rating on shares of Medtronic PLC in a research note on Thursday, August 24th. Finally, Royal Bank Of Canada reiterated a “buy” rating and issued a $90.00 price target on shares of Medtronic PLC in a research note on Monday, August 21st. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $88.98.

Medtronic PLC (NYSE:MDT) opened at 78.63 on Thursday. The company has a 50-day moving average of $80.40 and a 200-day moving average of $83.36. Medtronic PLC has a 52 week low of $69.35 and a 52 week high of $89.72. The firm has a market cap of $106.51 billion, a price-to-earnings ratio of 26.47 and a beta of 1.01.

Medtronic PLC (NYSE:MDT) last posted its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.04. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The business had revenue of $7.39 billion during the quarter, compared to the consensus estimate of $7.44 billion. During the same quarter last year, the company posted $1.03 earnings per share. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. Equities research analysts forecast that Medtronic PLC will post $4.77 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be issued a dividend of $0.46 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.84 dividend on an annualized basis and a yield of 2.34%. Medtronic PLC’s dividend payout ratio (DPR) is presently 61.95%.

In related news, CEO Omar Ishrak sold 140,407 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the completion of the sale, the chief executive officer now owns 668,503 shares in the company, valued at $54,569,899.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Bryan C. Hanson sold 12,000 shares of the firm’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $88.57, for a total transaction of $1,062,840.00. The disclosure for this sale can be found here. Company insiders own 0.31% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Alpine Woods Capital Investors LLC Boosts Position in Medtronic PLC (MDT)” was first published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/alpine-woods-capital-investors-llc-boosts-position-in-medtronic-plc-mdt/1609113.html.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.